Semisynthetic hydrophilic polyals

Biomacromolecules

Volumn 6, Issue 5, 2005, Pages 2659-2670

  Papisov, Mikhail I ^a   Hiller, Alexander ^a   Yurkovetskiy, Alexander ^a   Yin, Mao ^a   Barzana, Marlene ^a   Hillier, Shawn ^a   Fischman, Alan J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOMEDICAL ENGINEERING; CARBOHYDRATES; CELLS; HYDROPHILICITY; MEDICAL APPLICATIONS; MONOMERS; PHARMACOKINETICS; POLYMERIZATION;

HYDROPHILIC POLYALS; MACROMOLECULE INTERACTION; POLYALDOSES; POLYKETOSES;

BIOPOLYMERS;

ACETAL; ALCOHOL; BIOMATERIAL; CARBOHYDRATE; DEXTRAN; ETHYLENE DERIVATIVE; KETOSE; MONOMER; POLYMER; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADATION; BIOENGINEERING; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE TARGETING; HYPOTHESIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHARMACY; POLYMERIZATION; PREVALENCE; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARBOHYDRATES; CARBON; CATIONS; CROSS-LINKING REAGENTS; DEXTRANS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KETOSES; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MODELS, CHEMICAL; MODELS, MOLECULAR; OLIGOSACCHARIDES; OXYGEN; PENTETIC ACID; POLYMERS; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TEMPERATURE; TIME FACTORS; TISSUE ENGINEERING;

EID: 25844485952     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm0502157     Document Type: Article

References (28)

1. Papisov, M. I. Modeling in vivo transfer of long-circulating polymers (two classes of long circulating polymers and factors affecting their transfer in vivo). Special issue on long circulating drugs and drug carriers. Adv. Drug Delivery Rev. 1995, 16, 127-137.
2. Papisov, M. I. Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. Adv. Drug Delivery Rev. 1998, 32, 119-138.
3. Papisov, M.; Weissleder, R. Drug Delivery to lymphatic tissue. Crit. Rev. Ther. Drug Carrier Syst. 1996, 13, 57-84.
4. Jeanes, A. The a-D-glucopyranosidic linkages of dextrans: comparison of percentages from structural analysis by periodate oxidation and by methylation. Carbohydr. Res. 1979, 74, 31-40.
5. Ishak, M. F.; Painter, T. J. Kinetic evidence of hemiacetal formation during the oxidation of dextran in aqueous periodate. Carbohydr. Res. 1978, 64, 189-197.
6. Larsen, C. Dextran prodrugs - structure and stability in relation to therapeutic activity. Adv. Drug Delivery Rev. 1989, 3, 103-154.
7. Jeanes, A. Immunochemical and related interactions with dextrans reviewed in terms of improved structural information. Mol. Immunol. 1986, 23, 999-1028.
8. Osman, M. E.; Menzies, A. R.; Williams, P. A.; Phillips, G. O.; Baldwin, T. C. The molecular characterisation of the polysaccharide gum from Acacia senegal. Carbohydr. Res. 1993, 246, 303-318.
9. Bowie, J. U.; Trescony, P. V.; Gray, G. R. Analysis of linkage positions in saccharomyces cerevisiae -mannans by the reductive-cleavage method Carbohydr. Res. 1984, 125, 301-307.
10. Bubnis, W.; Ofner, C. The determination of epsilon-amino groups in soluble and poorly soluble proteinacious materials by a spectrophotometric method using trinitrobenzenesulfonic acid. Anal. Biochem. 1992, 297, 129-33.
11. Papisov, M. I.; Weissleder, R.; Brady, T. J. Diagnostic targeting of lymph nodes with polymeric imaging agents. In Targeted delivery of imaging agents; Torchilin, V. P., Ed.; CRC Press: Boca Raton, FL, 1995; pp 385-402.
12. Dubois, M.; Gilles, K. A.; Hamilton, J. K.; Rebers, P. A.; Smith, F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28, 350-356.
13. Papisov, M. I. Acyclic polyacetals from polysaccharides. ACS Symp. Ser. 2001, 786, 301-314.
14. Papisov, M. I.; Martin, C.; Poss, K.; Weissleder, R.; Brady, T. J. Amplification of steric effects in cooperative systems. 22nd International Symposium on Controlled Release of Bioactive Materials, Seattle, WA, 1995; Controlled Release Society, Deerfield, IL, 1995; pp 442-443.
15. Papisov, M. I. Theoretical models in developing sterically protected drug carriers. Eighth international symposium on recent advances in drug delivery systems, Abstracts; Salt Lake City, UT, 1997; University of Utah 1997; pp 184-185.
16. Papisov, M. I.; Schaffer, B. S.; Nossiff, N.; Bogdanov, A. A.; Weissleder, R.; Brady, T. J. Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution. Proceedings of Sixth International Conference on Magnetic Fluids, Paris, France; Ministére de la Recherche et de la Technologie, Paris, France, 1992; p 182.
17. Papisov, M. I.; Weissleder, R.; Schaffer, B. K.; Tsai, E.; Bogdanov, A. A., Jr.; Nossiff, N.; Bogdanova, A. V.; Brady, T. J. Lymphotropic contrast agents: in vivo transfer processes. Proceedings of the Society of Magnetic Resonance in Medicine, Twelfth Annual Scientific meeting New York; SMRM, Berkley, CA, 1993; p 499.
18. Berg, E. M.; Fasting, S.; Sellevold, O. F. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery? Anaestesia 1991, 46, 1033-1035.
19. Hardie, J. M.; Marsh, P. D. In Streptococci; Skinner, F. A., Quesnel, L. B., Eds.; Academic Press: London, 1978; pp 157-206.
20. Kochanowski, B.; Fischer, W.; Iida-Tanaka, N.; Ishizuka, I. Isomalto-oligosaccharide-containing lipoteichoic acid od Streptococcus sanguis. Basic structure. Eur. J. Biochem. 1993, 214, 747-755.
21. Kochanowski, B.; Leopold, K.; Fischer, W. Isomalto-oligosaccharide-containing lipoteichoic acid od Streptococcus sanguis. Microheterogeneity and distribution of chain substituents. Eur. J. Biochem. 1993, 214, 757-761.
22. Brade, L.; Brade, H.; Fisher, W. A 28 kDa protein of normal mouse serum binds lipopolysaccharides of gram-negative and lipoteichoic acids of gram-positive bacteria. Microb. Pathog. 1990, 9, 355-362.
23. Bkhakdi, S.; Klonisch, T.; Nuber, P.; Fischer, W. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 1991, 59, 4614-4620.
24. Keller, R.; Fischer, W.; Keist, R.; Bassetti, S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 1992, 60, 3664-3672.
25. Bogdanov, A. A.; Weissleder, R.; Frank, H. W.; Bogdanova, A. V.; Nossiff, N.; Schaeffer, B. K.; Tsai, E.; Papisov, M. I.; Brady, T. J. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993, 187, 701-6.
26. Papisov, M. I.; Weissleder, R.; Schaffer, B. K.; Tsai, E.; Bogdanov, A. A., Jr.; Nossiff, N.; Bogdanova, A. V.; Brady, T. J. Lymphotropic contrast agents: in vivo transfer processes. Proceedings of the Society of Magnetic Resonance in Medicine, Twelfth Annual Scientific meeting New York; SMRM, Berkley, CA, 1993; p 499.
27. Papisov, M. I.; Babich, J. W.; Dotto, P.; Barzana, M.; Hillier, S.; Graham-Coco, W.; Fischman, A. J. Model cooperative (multivalent) vectors for drug targeting. 25th Int. Symp. on Controlled Release of Bioactive Materials, 1998, Las Vegas, Nevada, USA.; Controlled Release Society, Deerfield, IL, 1998; pp 170-171.
28. Papisov, M. I.; Babich, J. W.; Barzana, M.; Hillier, S.; Graham-Coco, W.; Fischman, A. J. Model multivalent radiopharmaceuticals targeted with chemotactic peptide. The Society of Nuclear Medicine 45th Annual Meeting, 1998 Toronto, Canada. J. Nucl. Med. 1998, 39, 223P.